Safety Margin for Plasma Hyperviscosity in Cardiovascular Disease Patients after COVID-19 Vaccination for Thrombosis Prevention. [PDF]
Mungmunpuntipantip R, Wiwanitkit V.
europepmc +1 more source
Impact of Serum Uric Acid Concentration on the Risk of Cardiovascular Disease: A Cohort Study Conducted in Northern China. [PDF]
Nie Q +7 more
europepmc +1 more source
Cardiovascular Disease and Risk Factors in Women in Latin America and the Caribbean. [PDF]
Mesquita CT +23 more
europepmc +1 more source
Spirituality and Cardiovascular Disease: Valuing Cultural Sensitivity in Cardiology. [PDF]
Lucchetti G.
europepmc +1 more source
Pharmacogenomics and Cardiovascular Disease: Where are We and Where do We go from Here? [PDF]
Stein R, Beuren T, Cela LR, Ferrari F.
europepmc +1 more source
Acute Myocardial Infarction with Coronary Thrombosis in a Covid-19 Patient without Risk Factors for Cardiovascular Disease. [PDF]
Viana T +7 more
europepmc +1 more source
Alcohol Consumption and Its Association with Lifestyle in Individuals with and without Cardiovascular Disease. [PDF]
Godoy PH.
europepmc +1 more source
Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients. [PDF]
Sonkar SK +5 more
europepmc +1 more source
Association of Plasma Osmolality with Cardiovascular Disease Risk: Evidence from the National Health and Nutrition Examination Survey Database. [PDF]
Gao F, Shi Y, Chen Y, Lu S.
europepmc +1 more source
Sit-to-stand test as a complementary assessment in patients with cardiovascular disease. [PDF]
Avila-Valencia JC +3 more
europepmc +1 more source

